TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286 · see citing works

Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein

Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586 · see citing works

The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade

Coutard, B., Valle, C., de Lamballerie, X. N., Canard, B., Seidah, N. G., & Decroly, É. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104742 · Cited by 1,685 · see citing works

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

Matsuyama, S., Nao, N., Shirato, K., Kawase, M., Saito, S., Takayama, I., Nagata, N., Sekizuka, T., Katoh, H., Kato, F., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002589117 · Cited by 1,414 · see citing works

Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites

Belouzard, S., Chu, V. C., & Whittaker, G. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809524106 · Cited by 1,073 · see citing works

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

Simmons, G., Gosalia, D. N., Rennekamp, A. J., Reeves, J. D., Diamond, S. L., & Bates, P. F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505577102 · Cited by 1,041 · see citing works

Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis

Millet, J. K., & Whittaker, G. R. (2014) · Virus Research · doi:10.1016/j.virusres.2014.11.021 · Cited by 887 · see citing works

Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein

Millet, J. K., & Whittaker, G. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407087111 · Cited by 673 · see citing works

TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection

Iwata‐Yoshikawa, N., Okamura, T., Shimizu, Y., Hasegawa, H., Takeda, M., & Nagata, N. (2019) · Journal of Virology · doi:10.1128/jvi.01815-18 · Cited by 607 · see citing works

Protease inhibitors targeting coronavirus and filovirus entry

Zhou, Y., Vedantham, P., Lü, K., Agudelo, J., Carrion, R., Nunneley, J. W., Barnard, D. L., Pöhlmann, S., McKerrow, J. H., Renslo, A. R., et al. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.01.011 · Cited by 588 · see citing works

Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer

Walls, A. C., Tortorici, M. A., Bosch, B., Frenz, B., Rottier, P. J. M., DiMaio, F., Rey, F. A., & Veesler, D. (2016) · Nature · doi:10.1038/nature16988 · Cited by 539 · see citing works

Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus Entry

Kawase, M., Shirato, K., van der Hoek, L., Taguchi, F., & Matsuyama, S. (2012) · Journal of Virology · doi:10.1128/jvi.00094-12 · Cited by 517 · see citing works

Proteolytic Activation of Influenza Viruses by Serine Proteases TMPRSS2 and HAT from Human Airway Epithelium

Böttcher, E., Matrosovich, T. Y., Beyerle, M., Klenk, H., Garten, W., & Matrosovich, M. N. (2006) · Journal of Virology · doi:10.1128/jvi.01118-06 · Cited by 490 · see citing works

Host cell proteases controlling virus pathogenicity

Klenk, H., & Garten, W. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90123-6 · Cited by 466 · see citing works

Virus isolation and quantitation

Hierholzer, J. C., & Killington, R. A. (1996) · Elsevier eBooks · doi:10.1016/b978-012465330-6/50003-8 · Cited by 450 · see citing works

Type II Transmembrane Serine Proteases

Bugge, T. H., Antalis, T., & Wu, Q. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.021006 · Cited by 450 · see citing works

Middle East Respiratory Syndrome Coronavirus Infection Mediated by the Transmembrane Serine Protease TMPRSS2

Shirato, K., Kawase, M., & Matsuyama, S. (2013) · Journal of Virology · doi:10.1128/jvi.01890-13 · Cited by 448 · see citing works

Coronavirus Cell Entry Occurs through the Endo-/Lysosomal Pathway in a Proteolysis-Dependent Manner

Tait‐Burkard, C., Verheije, M. H., Wicht, O., van Kasteren, S. I., van Kuppeveld, F. J. M., Haagmans, B. L., Pelkmans, L., Rottier, P. J. M., Bosch, B., & de Haan, C. A. M. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004502 · Cited by 389 · see citing works

Ready, Set, Fuse! The Coronavirus Spike Protein and Acquisition of Fusion Competence

Heald-Sargent, T. A., & Gallagher, T. (2012) · Viruses · doi:10.3390/v4040557 · Cited by 322 · see citing works

Cathepsin L Functionally Cleaves the Severe Acute Respiratory Syndrome Coronavirus Class I Fusion Protein Upstream of Rather than Adjacent to the Fusion Peptide

Bosch, B., Bartelink, W., & Rottier, P. J. M. (2008) · Journal of Virology · doi:10.1128/jvi.00415-08 · Cited by 315 · see citing works

Characterization of a Highly Conserved Domain within the Severe Acute Respiratory Syndrome Coronavirus Spike Protein S2 Domain with Characteristics of a Viral Fusion Peptide

Madu, I. G., Roth, S. L., Belouzard, S., & Whittaker, G. R. (2009) · Journal of Virology · doi:10.1128/jvi.00079-09 · Cited by 299 · see citing works

Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism

Park, J.-E., Li, K., Barlan, A., Fehr, A. R., Perlman, S. M., McCray, P. B., & Gallagher, T. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608147113 · Cited by 299 · see citing works

Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell–cell fusion but does not affect virion entry

Follis, K. E., York, J., & Nunberg, J. H. (2006) · Virology · doi:10.1016/j.virol.2006.02.003 · Cited by 231 · see citing works

Morpholinos and their peptide conjugates: Therapeutic promise and challenge for Duchenne muscular dystrophy

Moulton, H. M., & Moulton, J. D. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.02.012 · Cited by 229 · see citing works

Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry

Shirato, K., Kawase, M., & Matsuyama, S. (2017) · Virology · doi:10.1016/j.virol.2017.11.012 · Cited by 227 · see citing works

Phenotypic Analysis of Mice Lacking the Tmprss2 -Encoded Protease

Kim, T. S., Heinlein, C. A., Hackman, R. C., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.3.965-975.2006 · Cited by 220 · see citing works

Precursor Processing by Kex2/Furin Proteases

Rockwell, N. C., Krysan, D. J., Komiyama, T., & Fuller, R. S. (2002) · Chemical Reviews · doi:10.1021/cr010168i · Cited by 201 · see citing works

Tmprss2 Is Essential for Influenza H1N1 Virus Pathogenesis in Mice

Hatesuer, B., Bertram, S., Nora, M., Bahgat, M. M., Nelson, P. S., Pöhlmann, S., & Schughart, K. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003774 · Cited by 198 · see citing works

Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents

Abes, S., Moulton, H. M., Clair, P., Prévôt, P., Youngblood, D. S., Wu, R. P., Iversen, P. L., & Lebleu, B. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.09.011 · Cited by 195 · see citing works

TMPRSS2 Is the Major Activating Protease of Influenza A Virus in Primary Human Airway Cells and Influenza B Virus in Human Type II Pneumocytes

Limburg, H., Harbig, A., Bestle, D., Stein, D. A., Moulton, H. M., Jaeger, J., Janga, H., Hardes, K., Koepke, J., Schulte, L. N., et al. (2019) · Journal of Virology · doi:10.1128/jvi.00649-19 · Cited by 171 · see citing works

The Host Protease TMPRSS2 Plays a Major Role in In Vivo Replication of Emerging H7N9 and Seasonal Influenza Viruses

Sakai, K., Ami, Y., Tahara, M., Kubota, T., Anraku, M., Abe, M., Nakajima, N., Sekizuka, T., Shirato, K., Suzaki, Y., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03677-13 · Cited by 165 · see citing works

TMPRSS2 Is a Host Factor That Is Essential for Pneumotropism and Pathogenicity of H7N9 Influenza A Virus in Mice

Tarnow, C., Engels, G., Arendt, A., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03799-13 · Cited by 147 · see citing works

Aprotinin and similar protease inhibitors as drugs against influenza

Op, Z., Klenk, H., & Wright, P. F. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.07.014 · Cited by 138 · see citing works

Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry

Shirato, K., Kanou, K., Kawase, M., & Matsuyama, S. (2016) · Journal of Virology · doi:10.1128/jvi.01387-16 · Cited by 137 · see citing works

The basic trypsin inhibitor of bovine pancreas IV. The linear sequence of the 58 amino acids

Kassell, B., Radicevic, M., Ansfield, M. J., et al. (1965) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(65)90749-7 · Cited by 133 · see citing works

Matriptase, HAT, and TMPRSS2 Activate the Hemagglutinin of H9N2 Influenza A Viruses

Baron, J., Tarnow, C., Mayoli-Nüssle, D., et al. (2012) · Journal of Virology · doi:10.1128/jvi.02320-12 · Cited by 132 · see citing works

Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation

Meyer, D., Sielaff, F., Hammami, M., Böttcher‐Friebertshäuser, E., Garten, W., & Steinmetzer, T. (2013) · Biochemical Journal · doi:10.1042/bj20130101 · Cited by 130 · see citing works

Inhibition of Furin by Polyarginine-containing Peptides

Kacprzak, M. M., Peinado, J. R., Than, M. E., Appel, J. R., Henrich, S., Lipkind, G. M., Houghten, R. A., Bode, W., & Lindberg, I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400484200 · Cited by 118 · see citing works

Type II transmembrane serine proteases

Szabo, R., Wu, Q., Dickson, R., Netzel-Arnett, S., Antalis, T., & Bugge, T. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-02-0071 · Cited by 104 · see citing works

Priming Time: How Cellular Proteases Arm Coronavirus Spike Proteins

Hoffmann, M., Hofmann-Winkler, H., & Pöhlmann, S. (2018) · Springer eBooks · doi:10.1007/978-3-319-75474-1_4 · Cited by 101 · see citing works

Inhibition of Influenza Virus Infection in Human Airway Cell Cultures by an Antisense Peptide-Conjugated Morpholino Oligomer Targeting the Hemagglutinin-Activating Protease TMPRSS2

Böttcher‐Friebertshäuser, E., Stein, D. A., Klenk, H., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01294-10 · Cited by 98 · see citing works

Influenza virus activating host proteases: Identification, localization and inhibitors as potential therapeutics

Garten, W., Braden, C., Arendt, A., Peitsch, C., Baron, J., Lu, Y., Pawletko, K., Hardes, K., Steinmetzer, T., & Böttcher‐Friebertshäuser, E. (2015) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2015.05.013 · Cited by 93 · see citing works

Cleavage Activation of the Influenza Virus Hemagglutinin and Its Role in Pathogenesis

Garten, W., & Klenk, H. (2008) · Monographs in virology · doi:10.1159/000151618 · Cited by 91 · see citing works

The Furin Inhibitor Hexa- d -Arginine Blocks the Activation ofPseudomonas aeruginosaExotoxin A In Vivo

Sarač, M. S., Cameron, A., & Lindberg, I. (2002) · Infection and Immunity · doi:10.1128/iai.70.12.7136-7139.2002 · Cited by 85 · see citing works

Protection against Anthrax Toxemia by Hexa- d -Arginine In Vitro and In Vivo

Sarač, M. S., Peinado, J. R., Leppla, S. H., & Lindberg, I. (2003) · Infection and Immunity · doi:10.1128/iai.72.1.602-605.2004 · Cited by 81 · see citing works

Novel Furin Inhibitors with Potent Anti‐infectious Activity

Hardes, K., Becker, G. L., Lu, Y., et al. (2015) · ChemMedChem · doi:10.1002/cmdc.201500103 · Cited by 78 · see citing works

Middle East Respiratory Syndrome Coronavirus Spike Protein Is Not Activated Directly by Cellular Furin during Viral Entry into Target Cells

Matsuyama, S., Shirato, K., Kawase, M., et al. (2018) · Journal of Virology · doi:10.1128/jvi.00683-18 · Cited by 70 · see citing works

The S2 Subunit of QX-type Infectious Bronchitis Coronavirus Spike Protein Is an Essential Determinant of Neurotropism

Cheng, J., Zhao, Y., Xu, G., Zhang, K., Jia, W., Sun, Y., Zhao, Y., Xue, J., Hu, Y., & Zhang, G. (2019) · Viruses · doi:10.3390/v11100972 · Cited by 68 · see citing works

Morpholino oligomers targeting the PB1 and NP genes enhance the survival of mice infected with highly pathogenic influenza A H7N7 virus

Gabriel, G., Nordmann, A., Stein, D. A., et al. (2008) · Journal of General Virology · doi:10.1099/vir.0.83449-0 · Cited by 56 · see citing works

Inhibition of influenza A H3N8 virus infections in mice by morpholino oligomers

Lupfer, C. R., Stein, D. A., Mourich, D. V., et al. (2008) · Archives of Virology · doi:10.1007/s00705-008-0067-0 · Cited by 53 · see citing works

Inhibition of Respiratory Syncytial Virus Infections With Morpholino Oligomers in Cell Cultures and in Mice

Lai, S., Stein, D. A., Guerrero-Plata, A., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.81 · Cited by 53 · see citing works

New 3-amidinophenylalanine-derived inhibitors of matriptase

Hammami, M., Rühmann, E., Maurer, E., et al. (2012) · MedChemComm · doi:10.1039/c2md20074k · Cited by 53 · see citing works

Inhibition of RNA Virus Infections with Peptide-Conjugated Morpholino Oligomers

Stein, D. A. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786071290 · Cited by 48 · see citing works

Homology Modeling of TMPRSS2 Yields Candidate Drugs That May Inhibit Entry of SARS-CoV-2 into Human CellsPreprint

Rensi, S., Altman, R. B., Liu, T., Lo, Y., McInnes, G., Derry, A., & Keys, A. M. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12009582.v1 · Cited by 48 · see citing works

Metabolic fate of14C-camostat mesylate in man, rat and dog after intravenous administration

Midgley, I., Hood, A. J., Proctor, P., et al. (1994) · Xenobiotica · doi:10.3109/00498259409043223 · Cited by 47 · see citing works

Hemagglutinin activating host cell proteases provide promising drug targets for the treatment of influenza A and B virus infections

Böttcher‐Friebertshäuser, E., Lu, Y., Meyer, D., Sielaff, F., Steinmetzer, T., Klenk, H., & Garten, W. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.001 · Cited by 47 · see citing works

Inhibition of Proprotein Convertases Abrogates Processing of the Middle Eastern Respiratory Syndrome Coronavirus Spike Protein in Infected Cells but Does Not Reduce Viral Infectivity

Gierer, S., Müller, M. A., Heurich, A., Ritz, D., Springstein, B. L., Karsten, C. B., Schendzielorz, A. B., Gnirß, K., Drosten, C., & Pöhlmann, S. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu407 · Cited by 39 · see citing works

Characterization of Proprotein Convertases and Their Involvement in Virus Propagation

Garten, W. (2018) · Springer eBooks · doi:10.1007/978-3-319-75474-1_9 · Cited by 39 · see citing works

Design, Synthesis, and Characterization of Macrocyclic Inhibitors of the Proprotein Convertase Furin

van, T. V. L., Ivanova, T., Hardes, K., Heindl, M. R., Morty, R. E., Böttcher‐Friebertshäuser, E., Lindberg, I., Than, M. E., Dahms, S. O., & Steinmetzer, T. (2019) · ChemMedChem · doi:10.1002/cmdc.201800807 · Cited by 37 · see citing works

Membrane-Anchored Serine Proteases: Host Cell Factors in Proteolytic Activation of Viral Glycoproteins

Böttcher‐Friebertshäuser, E. (2018) · Springer eBooks · doi:10.1007/978-3-319-75474-1_8 · Cited by 35 · see citing works

Inhibition of porcine reproductive and respiratory syndrome virus infection in piglets by a peptide-conjugated morpholino oligomer

Opriessnig, T., Patel, D., Wang, R., et al. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.04.012 · Cited by 34 · see citing works

Peptidomimetic furin inhibitor MI-701 in combination with oseltamivir and ribavirin efficiently blocks propagation of highly pathogenic avian influenza viruses and delays high level oseltamivir resistance in MDCK cells

Lu, Y., Hardes, K., Dahms, S. O., Böttcher‐Friebertshäuser, E., Steinmetzer, T., Than, M. E., Klenk, H., & Garten, W. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.05.006 · Cited by 33 · see citing works

Fibrinolysis Inhibitors: Potential Drugs for the Treatment and Prevention of Bleeding

Steinmetzer, T., Pilgram, O., Wenzel, B. M., & Wiedemeyer, S. J. A. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01060 · Cited by 33 · see citing works

The Antiviral Potential of Host Protease Inhibitors

Steinmetzer, T., & Hardes, K. (2018) · Springer eBooks · doi:10.1007/978-3-319-75474-1_11 · Cited by 26 · see citing works

Comparative clinical study of FOY and Trasylol in acute pancreatitis.

Tanaka, N., Tsuchiya, R., & Ishii, K. K. (1979) · PubMed · Cited by 21 · see citing works

Entry, Replication, Immune Evasion, and Neurotoxicity of Synthetically Engineered Bat-Borne Mumps Virus.

Krüger, N., Sauder, C., Hüttl, S., Papies, J., Voigt, K., Herrler, G., Hardes, K., Steinmetzer, T., Örvell, C., Drexler, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.018 · Cited by 16 · see citing works

Synthesis and characterization of novel fluorogenic substrates of coagulation factor XIII-A

Hardes, K., Hammamy, M. Z., & Steinmetzer, T. (2013) · Analytical Biochemistry · doi:10.1016/j.ab.2013.07.043 · Cited by 10 · see citing works

Addition ofo-aminobenzoic acid during Fmoc solid phase synthesis of a fluorogenic substrate containing 3-nitrotyrosine

Singh, S., Khaytin, I., Botsko, S., et al. (2002) · International Journal of Peptide Research and Therapeutics · doi:10.1007/bf02538387 · Cited by 3 · see citing works

TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes

Zang, R., Castro, M. F. G., McCune, B. T., Zeng, Q., Rothlauf, P. W., Sonnek, N. M., Liu, Z., Brulois, K. F., Wang, X., Greenberg, H. B., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abc3582 · Cited by 982 · see citing works

Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis

Johnson, B. A., Xie, X., Bailey, A. L., Kalveram, B., Lokugamage, K. G., Muruato, A., Zou, J., Zhang, X., Juelich, T., Smith, J. K., et al. (2021) · Nature · doi:10.1038/s41586-021-03237-4 · Cited by 694 · see citing works

COVID-19 mRNA vaccines: Platforms and current developments

Szabó, G. T., Mahiny, A. J., & Vlatkovic, I. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.02.016 · Cited by 308 · see citing works

Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes

Ravindra, N. G., Alfajaro, M. M., Gasque, V., Huston, N. C., Wan, H., Szigeti-Buck, K., Yasumoto, Y., Greaney, A. M., Habet, V., Chow, R. D., et al. (2021) · PLOS Biology · doi:10.1371/journal.pbio.3001143 · Cited by 258 · see citing works

The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19

Shah, H., Khan, M. S. H., Dhurandhar, N. V., & Hegde, V. (2021) · Acta Diabetologica · doi:10.1007/s00592-020-01636-z · Cited by 80 · see citing works

COVID-19 as a trigger for type 1 diabetes

Wang, Y., Guo, H., Wang, G., Zhai, J., & Du, B. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad165 · Cited by 50 · see citing works

Pharmacological features, health benefits and clinical implications of honokiol

Khatoon, F., Ali, S., Kumar, V., Elasbali, A. M., Alhassan, H. H., Alharethi, S. H., Islam, A., & Hassan, M. I. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2120541 · Cited by 50 · see citing works

Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development

Günl, F., Mecate-Zambrano, A., Rehländer, S., Hinse, S., Ludwig, S., & Brunotte, L. (2021) · Vaccines · doi:10.3390/vaccines9101052 · Cited by 27 · see citing works

Comparison of 10 emerging SARS-CoV-2 Variants: infectivity, animal tropism, and antibody neutralization

Zhang, L., Cui, Z., Li, Q., Yu, Y., Wu, J., Nie, J., Ding, R., Wang, H., Zhang, Y., Liu, S., et al. (2021) · doi:10.21203/rs.3.rs-492659/v1 · Cited by 5 · see citing works

Endoproteases other than furin have a role in hepatic proprotein processing

Ledgerwood, E. C., Brennan, S. O., & George, P. M. (1997) · IUBMB Life · doi:10.1080/15216549700203601 · Cited by 2 · see citing works

Furin Is the Major Proprotein Convertase Required for KISS1-to-Kisspeptin Processing

Harihar, S., Pounds, K. M., Iwakuma, T., Seidah, N. G., & Welch, D. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084958 · Cited by 23 · see citing works

Circulating Furin-Cleaved Proprotein Convertase Subtilisin/Kexin Type 9 Concentration Predicts Future Coronary Events in Japanese Subjects

Kataoka, Y., Harada‐Shiba, M., Hori, M., Watanabe, M., Kokubo, Y., Noguchi, T., Yasuda, S., & Miyamoto, Y. (2021) · JACC Asia · doi:10.1016/j.jacasi.2021.09.003 · Cited by 10 · see citing works

An inimitable proprotein convertase subtilisin kexin-9 (PCSK9) cleavage site VFAQ on Spike protein along with furin cleavage site makes SARS-CoV-2 uniquePreprint

Pandya, M. D., shukla, D., Shah, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.04.539453

Thrombin activation of protein C requires prior processing by a liver proprotein convertase

Essalmani, R., Susan‐Resiga, D., Guillemot, J., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.770040 · Cited by 15 · see citing works